Rhenman & Partners Asset Management AB
Q2 2014 13F-HR Holdings
Net value change ($000)
+3,839
(1.2%)
New positions
18
Sold out positions
12
Turnover %
27.2%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q1 2014
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| COVIDIEN PLC | 12,164 | 373.5% |
| VRTX | 9,619 | NEW |
| CAH | 6,787 | NEW |
| ACTAVIS INC | 5,576 | NEW |
| CELG | 5,313 | 65.2% |
| Clovis Oncology, Inc. | 3,727 | NEW |
| OVERSEAS SHIPHOLDING GROUP INC | 3,354 | 98.2% |
| BIIB | 3,211 | 25.6% |
| ACHILLION PHARMACEUTICALS INC | 2,498 | NEW |
| IDENIX PHARMACEUTICALS INC | 2,340 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| PFE | -11,338 | -100.0% |
| REGN | -10,397 | -62.1% |
| Actavis Plc | -5,249 | -100.0% |
| CARDINAL FINANCIAL CORP | -5,032 | -100.0% |
| PHARMACYCLICS INC | -4,816 | -49.4% |
| FOREST LAB | -4,443 | -100.0% |
| ABBV | -4,394 | -100.0% |
| TEVA | -4,392 | -77.0% |
| SYK | -2,898 | -69.6% |
| CVS | -2,852 | -43.1% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|